caffeic acid phenethyl ester has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algburi, FS; Caglayan, C; Taysi, ME; Taysi, S | 1 |
| Dhanjal, JK; Kaul, SC; Kumar, V; Sundar, D; Wadhwa, R | 1 |
1 review(s) available for caffeic acid phenethyl ester and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Caffeic acid phenethyl ester: A review on its pharmacological importance, and its association with free radicals, COVID-19, and radiotherapy.
Topics: Anti-Inflammatory Agents; Caffeic Acids; COVID-19; Free Radicals; Humans; Molecular Docking Simulation; Phenylethyl Alcohol; SARS-CoV-2 | 2023 |
1 other study(ies) available for caffeic acid phenethyl ester and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M
Topics: Caffeic Acids; COVID-19; Humans; Molecular Docking Simulation; Peptide Hydrolases; Phenylethyl Alcohol; Protease Inhibitors; SARS-CoV-2; Withanolides | 2021 |